Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Rosetta Genomics and Columbia University Collaborate for Cancer Diagnosis

Posted on: Monday, 17 December 2007, 09:00 CST

Rosetta Genomics and Columbia University Medical Center have announced that they will collaborate to develop microRNA-based diagnostic tests, early detection as well as prognosis, for diffuse large cell lymphoma, transformed follicular lymphoma and for chronic lymphocytic leukemia, three types of non-Hodgkin lymphoma.

Combining Rosetta Genomics know-how and proprietary technologies with Columbia University Medical Center's expertise in cancer, researchers are expected to screen for microRNAs that may be used as potential biomarkers and drug targets for these non-Hodgkin lymphoma indications.

Amir Avniel, president and CEO of Rosetta Genomics, said: "We are constantly expanding our pipeline with new diagnostic and therapeutic programs, both cancer and non-cancer related, in order to maximize our leading position in microRNA intellectual property and proprietary technologies. We are very excited to be collaborating with a leading research institution such as Columbia University Medical Center, and hope more collaboration will follow."


Source: Datamonitor

More News in this Category


Related Articles



Rating: 3.0 / 5 (14 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required

redOrbit Friends